BOSTON, Dec. 17, 2025 /PRNewswire/ — The Center for Information and Study on Clinical Research Participation (CISCRP) has launched an interactive data dashboardBOSTON, Dec. 17, 2025 /PRNewswire/ — The Center for Information and Study on Clinical Research Participation (CISCRP) has launched an interactive data dashboard

CISCRP Unveils First-Ever Interactive Data Dashboard for Global Clinical Research Insights

BOSTON, Dec. 17, 2025 /PRNewswire/ — The Center for Information and Study on Clinical Research Participation (CISCRP) has launched an interactive data dashboard, giving clinical research stakeholders customized access to data from the 2025 Perceptions & Insights study — the largest global survey of public and patient attitudes about and experiences with clinical research.

For the first time, sponsors, CROs, investigative sites, patient advocates, patients, and the public can explore, filter, and download de-identified data from more than 12,000 respondents worldwide. This free, powerful tool transforms CISCRP’s biannual study results into customizable, actionable insights to improve protocol design, patient engagement and education, and recruitment and retention strategies.

Key Features:

  • Custom Filtering: Segment data by region, demographics, and study characteristics.
  • Downloadable Views: Export dashboards or individual tabs as PowerPoint slides, PDF, or image files.
  • Transparency: Includes clear guidance on interpreting data and limitations.

“Data-driven decision-making is essential in clinical research,” said Annick de Bruin, Chief Research and Insights Officer, Research Services at CISCRP. “We are excited to offer a new interactive tool which makes it easier than ever to identify trends and tailor strategies for clinical development programs and community engagement initiatives.”

Why It Matters:

This dashboard marks a significant shift in how clinical research stakeholders’ access and  apply  patient insights. Beyond static reports, users can now explore global data interactively to identify trends in trust, awareness, and participation motivators.

Sponsors and CROs can segment insights by geography or demographics to inform protocol design and tailor recruitment and education strategies for diverse populations. Advocacy groups and clinical sites gain a clearer view of barriers and motivators, strengthening their outreach and enrollment efforts. Policymakers can assess and monitor trends in public and patient attitudes toward new and emerging clinical trial innovations—such as AI-enabled approaches and virtual or remote technologies—to inform policy and transparency initiatives.

By making these findings freely accessible, CISCRP empowers the entire research ecosystem to make more informed, patient-centered decisions.

Key Findings from the 2025 Study:

Below are some sample findings from the 2025 Perceptions and Insights Study. In addition to the data dashboard, findings from the 2025 study are summarized in CISCRP’s publicly available reports. Click here to view the detailed findings reports.

  • Altruism drives participation: Helping others and the desire to contribute to science remain top motivators for clinical research participation.
  • Social media matters: Digital outreach is playing a critical role in recruitment, as a significant number of participants reported first learning about trials through social media channels.
  • Trust remains a challenge: pharmaceutical companies continue to rank lower in public confidence compared to other stakeholders, highlighting the need for greater transparency and community engagement.
  • AI awareness grows: Respondents express comfort with AI generally but agree on the importance of transparency regarding its use.

Access the Dashboard:  Explore the interactive tool now at https://www.ciscrp.org/professional-services/perceptions-and-insights-studies/data-dashboards

CISCRP (Center for Information and Study on Clinical Research Participation, Inc.) is a globally recognized nonprofit dedicated to educating the public, supporting sponsors in clinical trial transparency, and engaging patients as partners throughout the research process. Through services like plain language summary development, patient advisory boards, and global educational programs, CISCRP works across 45+ countries to strengthen trust and improve health literacy. Through services such as plain-language summary development, patient advisory boards, custom research projects, and community education programs, CISCRP helps stakeholders across the clinical research enterprise recognize the value of participation in research, build trust, and achieve higher levels of patient and community engagement and partnership.

Cision View original content:https://www.prnewswire.com/news-releases/ciscrp-unveils-first-ever-interactive-data-dashboard-for-global-clinical-research-insights-302644450.html

SOURCE CISCRP

Market Opportunity
Everscale Logo
Everscale Price(EVER)
$0,00869
$0,00869$0,00869
-0,11%
USD
Everscale (EVER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

MMDA, sleep health organization launch drowsy driving campaign ahead of holidays

MMDA, sleep health organization launch drowsy driving campaign ahead of holidays

The Metro Manila Development Authority (MMDA) and the Philippine Society of Sleep Medicine (PSSM) on Wednesday launch an awareness campaign to prevent drowsy driving
Share
Bworldonline2025/12/18 12:05
A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release

A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release

The post A Netflix ‘KPop Demon Hunters’ Short Film Has Been Rated For Release appeared on BitcoinEthereumNews.com. KPop Demon Hunters Netflix Everyone has wondered what may be the next step for KPop Demon Hunters as an IP, given its record-breaking success on Netflix. Now, the answer may be something exactly no one predicted. According to a new filing with the MPA, something called Debut: A KPop Demon Hunters Story has been rated PG by the ratings body. It’s listed alongside some other films, and this is obviously something that has not been publicly announced. A short film could be well, very short, a few minutes, and likely no more than ten. Even that might be pushing it. Using say, Pixar shorts as a reference, most are between 4 and 8 minutes. The original movie is an hour and 36 minutes. The “Debut” in the title indicates some sort of flashback, perhaps to when HUNTR/X first arrived on the scene before they blew up. Previously, director Maggie Kang has commented about how there were more backstory components that were supposed to be in the film that were cut, but hinted those could be explored in a sequel. But perhaps some may be put into a short here. I very much doubt those scenes were fully produced and simply cut, but perhaps they were finished up for this short film here. When would Debut: KPop Demon Hunters theoretically arrive? I’m not sure the other films on the list are much help. Dead of Winter is out in less than two weeks. Mother Mary does not have a release date. Ne Zha 2 came out earlier this year. I’ve only seen news stories saying The Perfect Gamble was supposed to come out in Q1 2025, but I’ve seen no evidence that it actually has. KPop Demon Hunters Netflix It could be sooner rather than later as Netflix looks to capitalize…
Share
BitcoinEthereumNews2025/09/18 02:23
MREIT to acquire P16.22-B office towers in Taguig City via share swap

MREIT to acquire P16.22-B office towers in Taguig City via share swap

MREIT, Inc., the real estate investment trust (REIT) arm of listed Megaworld Corp., is set to acquire P16.22 billion worth of nine Grade A office buildings through
Share
Bworldonline2025/12/18 11:10